Infection and Drug Resistance (Jul 2023)

Second-Line Antiretroviral Treatment Outcomes and Predictors in Tigray Region, Ethiopia

  • Gidey K,
  • Mache A,
  • Hailu BY,
  • Asgedom SW,
  • Tassew SG,
  • Nirayo YL

Journal volume & issue
Vol. Volume 16
pp. 4903 – 4912

Abstract

Read online

Kidu Gidey, Abadi Mache, Berhane Yohannes Hailu, Solomon Weldegebreal Asgedom, Segen Gebremeskel Tassew, Yirga Legesse Nirayo Department of Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, EthiopiaCorrespondence: Kidu Gidey, Email [email protected]: Ethiopia has one of the highest HIV burdens in sub-Saharan Africa. Despite the fact that second-line antiretroviral therapy (ART) has been available for more than ten years, studies on its effectiveness are scarce.Objective: To assess treatment outcomes and predictors of unfavorable outcomes in HIV patients receiving second-line ART at Ayder Comprehensive Specialized Hospital and Mekelle Hospital.Materials and Methods: An institution-based retrospective cohort study was conducted in two hospitals in Tigray Region, Ethiopia. We evaluated 192 patients aged ≥ 15 years who were switched to second-line from November 2009 to May 2020 after failure of first-line ART. The primary outcome was the time from the initiation of second-line ART to the occurrence of unfavorable treatment outcomes (treatment failure, death, and loss to follow-up). We performed Kaplan–Meier survival estimates to calculate the cumulative incidence rates of unfavorable outcomes.Results: The mean age (SD) at the initiation of second-line ART was 39 (10.03) years, and the median CD4 cell count was 121 cells/microL. During a median follow-up of 4.6 years, 24 (12.5%) patients had died, 11 (5.7%) patients were lost to follow up, and 47 (24,4%) patients were experienced treatment failure. The incidence rates for unfavorable outcomes were 7.8 per 100 patients/years. Predictors for unfavorable outcomes were body mass index (BMI) < 18.5 (adjusted hazard ratio [aHR] = 2.51, 95% confidence interval (CI): 1.27– 4.95) and CD4 counts ≤ 100 cells/microL (aHR = 1.74, 95% CI: 1.09– 2.79). Despite the failure of second-line ART, none of the patients received third-line ART.Conclusion: The incidence rate of unfavorable treatment outcomes for second-line ART was found to be high. A low BMI and a low baseline CD4 count were significant predictors of unfavourable outcomes and should be given special consideration in HIV care. A third-line ART regimen should also be considered for people who have failed second-line ART.Keywords: human immunodeficiency virus, second-line ART, outcomes

Keywords